Clinical Trial Update: COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure [Phase 2]

View source ↗

Summary

Phase 2 trial update for COSMIC-HF evaluating an oral myosin activator for heart failure; results completed and posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Left Ventricular Ejection Fraction
• Left Ventricular Systolic Dysfunction

Drugs mentioned

• COSMIC-HF (myosin activator (not specified in excerpt))

Snippet

Sponsor: Cytokinetics | Conditions: Modified Release Oral Formulation, Left Ventricular Systolic Dysfunction | Phase 2 | Status: COMPLETED | Results posted: 2021-05-17